Ionis Pharmaceuticals (IONS) Misses Q3 EPS by 8c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q3 EPS of ($0.58), $0.08 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $133 million versus the consensus estimate of $161.63 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Ennis (EBF) Reports In-Line Q1 EPS
• BofA lists top 5 themes driving next $1tn in incremental semi sales